These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1967318

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
    Kleven MS, Koek W.
    Eur J Pharmacol; 1997 Feb 19; 321(1):1-4. PubMed ID: 9083778
    [Abstract] [Full Text] [Related]

  • 24. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
    Whetzel SZ, Shih YH, Georgic LM, Akunne HC, Pugsley TA.
    J Neurochem; 1997 Dec 19; 69(6):2363-8. PubMed ID: 9375667
    [Abstract] [Full Text] [Related]

  • 25. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    Acquas E, Di Chiara G.
    Eur J Pharmacol; 1999 Oct 27; 383(2):121-7. PubMed ID: 10585525
    [Abstract] [Full Text] [Related]

  • 26. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N, Miwa Y, Adachi K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):227-34. PubMed ID: 8858292
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA, Christofferson CL, Corbin A, DeWald HA, Demattos S, Meltzer LT, Myers SL, Shih YH, Whetzel SZ, Wiley JN.
    J Pharmacol Exp Ther; 1992 Dec 25; 263(3):1147-58. PubMed ID: 1361570
    [Abstract] [Full Text] [Related]

  • 28. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
    Hall H, Halldin C, Dijkstra D, Wikström H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G.
    Psychopharmacology (Berl); 1996 Dec 25; 128(3):240-7. PubMed ID: 8972543
    [Abstract] [Full Text] [Related]

  • 29. Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.
    Prinssen EP, Koek W, Kleven MS.
    Eur J Pharmacol; 1998 Aug 14; 355(1):19-22. PubMed ID: 9754934
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 14; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 33. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
    Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A.
    J Pharmacol Exp Ther; 2004 Jun 14; 309(3):936-50. PubMed ID: 14978196
    [Abstract] [Full Text] [Related]

  • 34. Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens.
    Fusa K, Saigusa T, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2002 Jul 19; 448(2-3):143-50. PubMed ID: 12144934
    [Abstract] [Full Text] [Related]

  • 35. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul 19; 333(3):205-18. PubMed ID: 3762735
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.
    Mierau J, Schingnitz G.
    Eur J Pharmacol; 1992 May 14; 215(2-3):161-70. PubMed ID: 1356788
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.